Document is current
Any future updates will be listed below
-
Authors
Shu, Pei
Li, Xiaoyu
Zhou, Qi
Li, Guiling
Zhang, Keqiang
Yuan, Li
Liu, Yixian
Li, Qiu
Wang, Yongsheng
Xie, Hui
Zheng, Li
-
Funding
Funding for this research was provided by:
Antengene
- License Information
-
More Information
Article History
Received: 17 November 2024
Revised: 30 April 2025
Accepted: 26 May 2025
First Online: 25 June 2025
Competing interests
: Dr. Xie reported being an employee of Antengene Corporation. The remaining authors declared no competing interests.
: This study was reviewed and approved by the Institutional Review Board of West China Hospital, Sichuan University. Written informed consent was obtained from each patient prior to screening. This study was registered at ClinicalTrial.gov (NCT 04337463). Studies were conducted in compliance with the Declaration of Helsinki and received approval from institutional review boards.
